Related Experiment Video
Updated: Apr 22, 2026

05:12
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
Published on: May 12, 2023
5.8K
Super-refractory status epilepticus in West China
Acta Neurologica Scandinavica
|October 15, 2014
Summary
Super-refractory status epilepticus (SRSE) affects 12.2% of status epilepticus (SE) cases, often stemming from acute encephalitis. SRSE presents a significant mortality risk (50%) and can lead to epilepsy in survivors.
Area of Science:
- Neurology
- Critical Care Medicine
- Epileptology
Background:
- Status epilepticus (SE) is a neurological emergency with varying outcomes.
- Refractory status epilepticus (RSE) and super-refractory status epilepticus (SRSE) represent more severe forms requiring specialized management.
- Understanding the epidemiology and risk factors of these SE subtypes is crucial for improving patient care.
Purpose of the Study:
- To determine the frequency, mortality rates, and risk factors associated with non-refractory SE (NRSE), RSE, and SRSE.
- To compare the etiological profiles and clinical characteristics across these SE categories.
- To identify predictors for the development of SRSE.
Main Methods:
- A retrospective study analyzing clinical data of 98 patients diagnosed with SE.
- Data collection spanned from January 2009 to December 2012 at West China Hospital.
- Statistical analysis was performed to compare patient groups based on SE refractoriness.
Main Results:
- SRSE constituted 12.2% of SE cases, with NRSE at 67.3% and RSE at 20.4%.
- Acute encephalitis was the primary cause of SRSE (67.7%), contrasting with epilepsy as the main cause for NRSE.
- SRSE exhibited a significantly higher mortality rate (50%) compared to overall SE (7.1%).
Conclusions:
- SRSE is a significant subtype of SE, occurring in approximately 12.2% of cases and posing a substantial clinical challenge.
- Acute encephalitis and first-episode SE are identified as risk factors for developing SRSE.
- Survivors of SRSE often develop symptomatic epilepsy, highlighting the long-term neurological sequelae.